메뉴 건너뛰기




Volumn 51, Issue 21, 2008, Pages 6980-7004

Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 (5,7 DIFLUORO 1H INDOL 3 YL)PROPYLAMINO] 8 FLUOROCHROMAN 5 CARBOXYLIC ACID; 3 [[3 (5 1H INDOL 3 YL)PROPYL]AMINO]CHROMANE 5 CARBOXAMIDE; 3 [[3 (5 CHLORO 1H INDOL 3 YL)PROPYL]AMINO] 8 FLUOROCHROMANE 5 CARBOXAMIDE; 3 [[3 (5 CYANO 1H INDOL 3 YL)PROPYL]AMINO] 8 FLUOROCHROMANE 5 CARBOXAMIDE; 3 [[3 (7 CHLORO 1H INDOL 3 YL)PROPYL]AMINO] 8 FLUOROCHROMANE 5 CARBOXAMIDE; 3 [CYCLOBUTYL[3 (5 FLUORO 1H INDOL 3 YL)PROPYL]AMINO] 8 FLUOROCHROMANE 5 CARBOXAMIDE; 3 AMINO 8 CHLOROCHROMANE 5 CARBOXAMIDE; 3 AMINO 8 FLUORO N METHYLCHROMANE 5 CARBOXAMIDE; 3 AMINO 8 FLUOROCHROMANE 5 CARBOXAMIDE; 3 AMINOCHROMANE 5 CARBOXAMIDE; 5 CARBAMOYL 8 FLUORO 3 AMINO 3,4 DIHYDRO 2H 1 BENZOPYRAN; 8 CHLORO 3 [[3 (5 FLUORO 1H INDOL 3 YL)PROPYL]AMINO]CHROMANE 5 CARBOXAMIDE; 8 FLUORO 3 [[3 (5 FLUORO 1H INDOL 3 YL)PROPYL]AMINO] N METHYLCHROMANE 5 CARBOXAMIDE; 8 FLUORO 3 [[3 (6 FLUORO 1H INDOL 3 YL)PROPYL]AMINO]CHROMANE 5 CARBOXAMIDE; 8 FLUORO 3 [[3 (7 METHOXY 1H INDOL 3 YL)PROPYL]AMINO]CHROMANE 5 CARBOXAMIDE; 8 FLUORO N [3 (5 FLUORO 1H INDOL 3 YL)PROPYL] 5 METHOXY N PROPYLCHROMAN 3 AMINE; 8 FLUORO N [3 (FLUORO 1H INDOL 3 YL)PROPYL] 5 METHOXY N PROPYLCHROMAN 3 AMINE; 8 FLUORO N METHYL 2H CHROMENE 5 CARBOXAMIDE; AMIDE; ANTIDEPRESSANT AGENT; BENZOPYRAN DERIVATIVE; CHROMAN DERIVATIVE; CYCLOBUTANE DERIVATIVE; N [3 (5 FLUORO 1H INDOL 3 YL)PROPYL] 5 METHOXY N PROPYLCHROMAN 3 AMINE; N CYCLOBUTYL N [3 (5 FLUORO 1H INDOL 3 YL)PROPYL] 5 METHOXYCHROMAN 3 AMINE; NITROGEN; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; STRAIGHT CHAIN ALKYL GROUP; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 56249142793     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm8007097     Document Type: Article
Times cited : (28)

References (44)
  • 2
    • 29544445541 scopus 로고    scopus 로고
    • Remission and recovery in depression treatment
    • Trivedi, M. H.; Kleiber, B.; Greer, T. L. Remission and recovery in depression treatment. Drug Dev. Res. 2005, 65, 335-343.
    • (2005) Drug Dev. Res , vol.65 , pp. 335-343
    • Trivedi, M.H.1    Kleiber, B.2    Greer, T.L.3
  • 3
    • 0019806188 scopus 로고
    • Adverse effects of antidepressant drugs. Part 1: Monoamine oxidase inhibitors and tricyclics
    • Blackwell, B. Adverse effects of antidepressant drugs. Part 1: monoamine oxidase inhibitors and tricyclics. Drugs 1981, 21, 201-219.
    • (1981) Drugs , vol.21 , pp. 201-219
    • Blackwell, B.1
  • 4
    • 52449122039 scopus 로고    scopus 로고
    • Recent approaches to novel antidepressant therapy
    • Evrard, D. A.; Harrison, B. L. Recent approaches to novel antidepressant therapy. Annu. Rep. Med. Chem. 1999, 34, 1-9.
    • (1999) Annu. Rep. Med. Chem , vol.34 , pp. 1-9
    • Evrard, D.A.1    Harrison, B.L.2
  • 5
    • 1642308531 scopus 로고    scopus 로고
    • Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression
    • and references therein
    • Katz, M. M.; Tekell, J. L.; Bowden, C. L.; Brannan, S.; Houston, J. P.; Berman, N.; Frazer, A. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 2004, 29, 566-579, and references therein.
    • (2004) Neuropsychopharmacology , vol.29 , pp. 566-579
    • Katz, M.M.1    Tekell, J.L.2    Bowden, C.L.3    Brannan, S.4    Houston, J.P.5    Berman, N.6    Frazer, A.7
  • 6
    • 0029064827 scopus 로고
    • Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo
    • Kreiss, D. S.; lucki, I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 1995, 274, 866-876.
    • (1995) J. Pharmacol. Exp. Ther , vol.274 , pp. 866-876
    • Kreiss, D.S.1    lucki, I.2
  • 7
    • 0031690668 scopus 로고    scopus 로고
    • New approaches to rapid onset antidepressants
    • (a) Briner, K.; Dodel, R. C. New approaches to rapid onset antidepressants. Curr. Pharm. Des. 1998, 4, 291-302.
    • (1998) Curr. Pharm. Des , vol.4 , pp. 291-302
    • Briner, K.1    Dodel, R.C.2
  • 8
    • 0008845504 scopus 로고    scopus 로고
    • 1A receptor antagonists: Historical perspective and therapeutic targets
    • 1A receptor antagonists: historical perspective and therapeutic targets. Serotonin 1997, 2, 299-309.
    • (1997) Serotonin , vol.2 , pp. 299-309
    • Schechter, L.E.1    Kelly, M.G.2
  • 9
    • 0029161526 scopus 로고
    • Selective serotonin/noradrenaline reuptake site inhibitors (SNRIs)
    • Artigas, F. Selective serotonin/noradrenaline reuptake site inhibitors (SNRIs). CNS Drugs 1995, 4, 79-89.
    • (1995) CNS Drugs , vol.4 , pp. 79-89
    • Artigas, F.1
  • 10
    • 33846391983 scopus 로고    scopus 로고
    • Recent strategies for the development of new antidepressant drugs
    • Evrard, D. A. Recent strategies for the development of new antidepressant drugs. Annu. Rep. Med. Chem. 2006, 41, 23-38.
    • (2006) Annu. Rep. Med. Chem , vol.41 , pp. 23-38
    • Evrard, D.A.1
  • 11
    • 0027456795 scopus 로고
    • Venlafaxine: A new dimension in antidepressant pharmacotherapy
    • Montgomery, S. A. Venlafaxine: a new dimension in antidepressant pharmacotherapy. J. Clin. Psychiatry 1993, 54, 119-126.
    • (1993) J. Clin. Psychiatry , vol.54 , pp. 119-126
    • Montgomery, S.A.1
  • 12
    • 21244493207 scopus 로고    scopus 로고
    • Venlafaxin XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo
    • Shelton, C.; Entsuah, R.; Padmanabhan, S. K.; Vinall, P. E. Venlafaxin XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo. Int. Clin. Psychopharmacol. 2005, 20, 233-238.
    • (2005) Int. Clin. Psychopharmacol , vol.20 , pp. 233-238
    • Shelton, C.1    Entsuah, R.2    Padmanabhan, S.K.3    Vinall, P.E.4
  • 13
    • 18844370877 scopus 로고    scopus 로고
    • The dual transporter inhibitor duloxetine: A review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression
    • Bymaster, F. P.; Lee, T. C.; Knadler, M. P.; Detke, M. J.; Iyengar, S. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Curr. Pharm. Des. 2005, 11, 1475-1493.
    • (2005) Curr. Pharm. Des , vol.11 , pp. 1475-1493
    • Bymaster, F.P.1    Lee, T.C.2    Knadler, M.P.3    Detke, M.J.4    Iyengar, S.5
  • 14
    • 1542404781 scopus 로고    scopus 로고
    • Effectiveness of pindolol plus serotonin uptake inhibitors in depression, a meta-analysis of early and late outcomes from randomized controlled trials
    • and references therein
    • Ballesteros, J.; Callado, L. F. Effectiveness of pindolol plus serotonin uptake inhibitors in depression, a meta-analysis of early and late outcomes from randomized controlled trials. J. Affective Disord. 2004, 79, 137-147, and references therein.
    • (2004) J. Affective Disord , vol.79 , pp. 137-147
    • Ballesteros, J.1    Callado, L.F.2
  • 15
    • 0030929916 scopus 로고    scopus 로고
    • 1A receptor antagonists in the dorsal Raphe pathway: Role of somatodendritic autoreceptors
    • 1A receptor antagonists in the dorsal Raphe pathway: role of somatodendritic autoreceptors. J. Neurochem. 1997, 68, 2593-2603.
    • (1997) J. Neurochem , vol.68 , pp. 2593-2603
    • Romero, L.1    Arigas, F.2
  • 16
    • 0031864268 scopus 로고    scopus 로고
    • The use of pindolol to potentiate antidepressant medication
    • Blier, P.; Bergeron, R. J. The use of pindolol to potentiate antidepressant medication. J. Clin. Psychiatry 1998, 59 (Suppl. 5), 16-23.
    • (1998) J. Clin. Psychiatry , vol.59 , Issue.SUPPL. 5 , pp. 16-23
    • Blier, P.1    Bergeron, R.J.2
  • 17
    • 0033135316 scopus 로고    scopus 로고
    • The use of pindolol with fluoxetine in the treatment of major depression: Final results from a double-blind, placebo-controlled trial
    • Berman, R. M.; Anand, A.; Cappiello, A.; Miller, H. L.; Xu, X. S.; Oren, D. A.; Charney, D. S. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biol. Psychiatry 1999, 45, 1170-1177.
    • (1999) Biol. Psychiatry , vol.45 , pp. 1170-1177
    • Berman, R.M.1    Anand, A.2    Cappiello, A.3    Miller, H.L.4    Xu, X.S.5    Oren, D.A.6    Charney, D.S.7
  • 18
    • 0032936568 scopus 로고    scopus 로고
    • Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: An in vivo microdialysis and electrophysiological study
    • Gartside, S. E.; Clifford, E. M.; Cowen, P. J.; Sharp, T. Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. Br. J. Pharmacol. 1999, 127, 145-152.
    • (1999) Br. J. Pharmacol , vol.127 , pp. 145-152
    • Gartside, S.E.1    Clifford, E.M.2    Cowen, P.J.3    Sharp, T.4
  • 19
    • 0036905983 scopus 로고    scopus 로고
    • Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: An in-vivo microdialysis study
    • Beyer, C. E.; Boikess, S.; Luo, B.; Dawson, L. A. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J. Psychopharmacol 2002, 16, 297-304.
    • (2002) J. Psychopharmacol , vol.16 , pp. 297-304
    • Beyer, C.E.1    Boikess, S.2    Luo, B.3    Dawson, L.A.4
  • 24
    • 0032403624 scopus 로고    scopus 로고
    • 1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. Bioorg. Med. Chem. Lett. 1998, 8, 3423-3428.
    • 1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. Bioorg. Med. Chem. Lett. 1998, 8, 3423-3428.
  • 30
    • 56249124838 scopus 로고    scopus 로고
    • Hammarberg, E. M, Johansson, L. G, Ross, S. B, Thorberg, S. O. 3-(N-Isopropyl-N-n-propylamino)-5-(N-isopropyl) carbamoylchroman. WO 93/07135, April 15, 1993
    • Hammarberg, E. M.; Johansson, L. G.; Ross, S. B.; Thorberg, S. O. 3-(N-Isopropyl-N-n-propylamino)-5-(N-isopropyl) carbamoylchroman. WO 93/07135, April 15, 1993.
  • 31
    • 56249146566 scopus 로고    scopus 로고
    • Evenden, J. L.; Hammarberg, E. M.; Hansson, H. S.; Hellberg, S. E.; Johansson, L. G.; Lundkvist, J. R. M.; Ross, S. B.; Sohn, D. D.; Thorberg, S. O. (R)-5-Carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro- 2H-1-benzopyrans. U.S. 5,616,610, April 1, 1997.
    • Evenden, J. L.; Hammarberg, E. M.; Hansson, H. S.; Hellberg, S. E.; Johansson, L. G.; Lundkvist, J. R. M.; Ross, S. B.; Sohn, D. D.; Thorberg, S. O. (R)-5-Carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro- 2H-1-benzopyrans. U.S. 5,616,610, April 1, 1997.
  • 32
    • 56249087475 scopus 로고    scopus 로고
    • Hanson, S.; Johansson, L.; Sohn, D. D. Process for the manufacture of 3-N,N-Dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5- carboxamide. U.S. 6,197,978 B1, March 6, 2001.
    • Hanson, S.; Johansson, L.; Sohn, D. D. Process for the manufacture of 3-N,N-Dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5- carboxamide. U.S. 6,197,978 B1, March 6, 2001.
  • 33
    • 56249098550 scopus 로고    scopus 로고
    • Hatzenbuhler, N. T.; Evrard, D. A.; Mewshaw, R. E.; Zhou, D.; Shah, U. S.; Inghrim, J. A.; Lenicek, S. E.; Baudy, R. B.; Butera, J. A.; Sabb, S. L.; Failli, A. A.; Ramamoorthy, P. S. A Preparation of 3-Aminochroman and 2-Aminotetralin Derivatives, Useful in the Treatment of Serotonin-Mediated Disorders. WO 2005/012291, February 10, 2005.
    • Hatzenbuhler, N. T.; Evrard, D. A.; Mewshaw, R. E.; Zhou, D.; Shah, U. S.; Inghrim, J. A.; Lenicek, S. E.; Baudy, R. B.; Butera, J. A.; Sabb, S. L.; Failli, A. A.; Ramamoorthy, P. S. A Preparation of 3-Aminochroman and 2-Aminotetralin Derivatives, Useful in the Treatment of Serotonin-Mediated Disorders. WO 2005/012291, February 10, 2005.
  • 34
    • 0001032345 scopus 로고
    • tert-butyl N-acylimidodicarbonates as isolable acylating agents: Mild conversion of primary carboxamides to substituted amides
    • Davidsen, S. K.; May, P. D.; Summers, J. B. Di-tert-butyl N-acylimidodicarbonates as isolable acylating agents: mild conversion of primary carboxamides to substituted amides. J. Org. Chem. 1991, 56, 5482-5485.
    • (1991) J. Org. Chem , vol.56 , pp. 5482-5485
    • Davidsen, S.K.1    May, P.D.2    Summers, J.B.D.3
  • 36
    • 0036900930 scopus 로고    scopus 로고
    • Total synthesis of the cyclic peptide argyrin B
    • Ley, S. V.; Priour, A. Total synthesis of the cyclic peptide argyrin B. Eur. J. Org. Chem. 2002, 3995-4004.
    • (2002) Eur. J. Org. Chem , pp. 3995-4004
    • Ley, S.V.1    Priour, A.2
  • 37
    • 0000052926 scopus 로고
    • Selective mono-alkylation of carbon nucleophiles with gramine
    • Somei, M.; Karasawa, Y.; Kaneko, C. Selective mono-alkylation of carbon nucleophiles with gramine. Heterocycles 1981, 16, 941-949.
    • (1981) Heterocycles , vol.16 , pp. 941-949
    • Somei, M.1    Karasawa, Y.2    Kaneko, C.3
  • 40
    • 0029154207 scopus 로고
    • Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in chloriocarcinoma cells
    • Ramamoorthy, J. D.; Ramamoorthy, S.; Papapetropoulos, A.; Catravas, J. D.; Leibach, F. H.; Ganapathy, V. Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in chloriocarcinoma cells. J. Biol. Chem. 1995, 270, 17189-17195.
    • (1995) J. Biol. Chem , vol.270 , pp. 17189-17195
    • Ramamoorthy, J.D.1    Ramamoorthy, S.2    Papapetropoulos, A.3    Catravas, J.D.4    Leibach, F.H.5    Ganapathy, V.6
  • 41
    • 0021892571 scopus 로고
    • 3H]8-Hydroxy-2-(di-n-propylamino) tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain
    • 3H]8-Hydroxy-2-(di-n-propylamino) tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J. Neurochem. 1985, 44, 1685-1696.
    • (1985) J. Neurochem , vol.44 , pp. 1685-1696
    • Hall, M.D.1    El Mestikawy, S.2    Emerit, M.B.3    Pichat, L.4    Hamon, M.5    Gozlan, H.6
  • 42
    • 0027313323 scopus 로고
    • 35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: Antagonist studies
    • 35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br. J. Pharmacol. 1993, 109, 1120-1127.
    • (1993) Br. J. Pharmacol , vol.109 , pp. 1120-1127
    • Larenzo, S.1    Birdsall, N.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.